Summary
CI-973 is a new platinum compound with antitumor properties that is currently undergoing phase II clinical trials. A high-performance liquid chromatographic (HPLC) assay was developed and validated for ultrafiltrates of human plasma and urine to support phase I clinical trials. Plasma ultrafiltrate (0.5 ml) was extracted using C18 solid-phase cartridges. Urine was diluted 10-fold and extracted first with SAX solid-phase cartridges and then with C18 cartridges. For both matrices, the eluate from the C18 cartridges was injected directly. A Whatman PAC 10 column (4.6×250 mm, 10-μm particle size) and ultraviolet detection at 205 nm were used for both analyses. The mobile-phase buffer was 0.05m sodium perchlorate (pH 2.3). The mobile-phase acetonitrile: buffer ratio, column temperature, and flow rate were 89∶11 (v/v), 40°C, and 2.0 ml/min, respectively, for the plasma ultrafiltrate assay and 85∶15 (v/v), 50°C, and 1.0 ml/min, respectively, for the urine ultrafiltrate assay. Standard curves were linear from 0.25 to 500 μg/ml and from 1.0 to 250 μg/ml for the plasma and urine assays, respectively. The accuracy of the assay lay within 4.5% of the nominal values, and the precision was 6.2%; the recovery of CI-973 varied from 79.2% to 105%. CI-973 remains stable in plasma for at least 6 h, at room temperature, in ultrafiltrates of both matrices for at least 15 days at −72°C, and in water for at least 6 months at −72°C.
Similar content being viewed by others
References
Duncan GF, Faulkner HC III, Farmen RH, Pittman KA (1988) Liquid chromatographic procedure for the quantitative analysis of carboplatin in beagle dog plasma ultrafiltrate. J Pharm Sci 77: 273
Elferink F, Vijgh WJF van der, Pinedo HM (1986) On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation. Anal Chem 58: 2293
Gaver RC, Deeb G (1986) High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine. Cancer Chemother Pharmacol 16: 201
Gaver RC, George AM, Deeb G (1987) In-vitro stability, plasma protein binding and blood cell partitioning of [14C]-carboplatin. Cancer Chemother Pharmacol 20: 271
Gaver RC, George AM, Duncan GF, Morris AD Deeb G, Faulkner HC, Farmen RH (1988) The disposition of carboplatin in the beagle dog. Cancer Chemother Pharmacol 21: 197
Gaver RC, Colombo N, Green MD, George AM, Deeb G, Morris AD, Canetta RM, Speyer JL, Farmen RH, Muggia FM (1988) The disposition of carboplatin in ovarian cancer patients. Cancer Chemother Pharmacol 22: 263
Gooijer C, Veltkamp AC, Bauman RA, Velthorst NH, Frei RW, Vijgh WJF van der (1984) Analysis of platinum complexes by liquid chromatography with quenched phosphorescence detection. J Chromatogr 312: 337
Kraker AJ, Moore CW, Leopold WR, Takahashi K (1988) Preclinical characterization of the in vitro and in vivo activity of [1,1′-cyclobutanedicarboxylato(2-)-0,0′] (2-methyl-1,4-butanediamine-N,N′) PT (NK-121/CI-973). Proc Am Assoc Cancer Res 29: 344
Kraker AJ, Moore CW, Roberts BJ, Leopold WR, Elliott WL (1992) Preclinical antitumor activity of CI-973. Invest New Drugs 9 (in press)
Krull IS, Ding X-D, Braverman S, Selavka C, Hochberg F, Sternson LA (1983) Trace analysis for cis-platinum anti-cancer drugs via LCEC. J Chromatogr Sci 21: 166
Marsh KC, Sternson LA, Repta AJ (1984) Post-column reaction detector for platinum (II) antineoplastic agents. Anal Chem 56: 491
Poile AF, Conlon RD (1981) Numerical spectroscopy: absorbance index technique and algorithm for qualitative analysis in liquid chromatography. J Chromatogr 204: 149
Riley CM (1988) Bioanalysis of cisplatin analogues — a selective review. J Pharm Biomed Appl 6: 669
Riley CM, Sternson LA (1984) Recent advances in the clinical analysis of cisplatin. Pharm Int 5: 15
Rocci ML, Jusko WJ (1983) LAGRAN program for area and moments in pharmacokinetic analysis. Comput Methods Programs Biomed 16: 203
Waal WAJ de, Maessen FJMJ, Kraak JC (1990) Analytical methodologies for the quantitation of platinum anti-cancer drugs and related compounds in biological media. J Pharm Biomed Appl 8: 1
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bullen, W.W., Andress, L.D., Chang, T. et al. A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates. Cancer Chemother. Pharmacol. 30, 193–198 (1992). https://doi.org/10.1007/BF00686311
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686311